Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of...

Descripción completa

Detalles Bibliográficos
Autores principales: Prins, Martin H, Lensing, Anthonie WA, Bauersachs, Rupert, van Bellen, Bonno, Bounameaux, Henri, Brighton, Timothy A, Cohen, Alexander T, Davidson, Bruce L, Decousus, Hervé, Raskob, Gary E, Berkowitz, Scott D, Wells, Philip S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850944/
https://www.ncbi.nlm.nih.gov/pubmed/24053656
http://dx.doi.org/10.1186/1477-9560-11-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850944/
https://www.ncbi.nlm.nih.gov/pubmed/24053656
http://dx.doi.org/10.1186/1477-9560-11-21

Ejemplares similares